commercial
New Rapid Tests for ESbL Detection The Kanto Chemical Company, Japan has recently appointed Mast Group as their authorised representative and exclusive European distributor for their Cica Beta range of tests for extended spectrum beta lactamase (ESbL) detection. The Cica Beta products incorporate the use of a novel chromogenic compound to differentiate between the various beta lactamase enzymes and subsequently permit confirmation of an organism as an ESbL, Metallo - beta lactamase (MBL), or AmpC producer. Separate kits are available for each type of beta lactamase enzyme and each kit is colour coded for simple identification. The kits can be used individually or in combination for comprehensive enzyme profiling. The kits are easy to use; suspect colonies are streaked onto each strip and identification is made by a clear colour change from yellow to red. Results are available within 15 minutes permitting rapid and accurate identification. The Cica Beta tests supplement the existing range of Mast's susceptibility and identification products and confirm our dominance as the market leader in ESbL detection.
information Are you a corporate member of the Society? If so, this section of Microbiologist is for you. Here you can publish short press releases, acquisition notices, news of new staff appointments, technical developments and much more. Each corporate member of the society may publish up to 200 words on a topic related to their field of activity in each issue of Microbiologist. For further information please contact Lucy Harper by email at: lucy@sfam.org.uk Both corporate members and ordinary members of the Society will find a wealth of useful information and resources in this section.
54
Invitrogen launch new Application Notes Invitrogen Environmental Diagnostics (formerly Dynal Biotech Microbiology) has recently launched a new series of Application Notes which highlight new or interesting product applications or developments. The Application Notes are written by customers or research and development scientists. Currently there are four titles available in this series: 1. Enhanced Automated Immunomagnetic Separation (eAIMS) for Escherichia coli O157 2. Norwegian Institute for Food and Environmental Analysis response to an “E. coli Outbreak” (using Dynabeads® EPEC/VTEC O103) 3. Getting more out of US EPA Method 1623: Cryptosporidium and Giardia in water by filtration/IMS/FA 4. Automated IMS (AIMS) using the BeadRetriever™ instrument for the detection of Cryptosporidium oocycts from environmental water samples further information visit: www.invitrogen.com/microbiology or contact david.wareing@invitrogen.com
Focus on Pall Medical
Bio-Rad Laboratories are pleased to announce the launch of our new chromogenic media, SaSELECT, for the isolation and direct identification of Staphylococcus aureus. This complements our existing MRSASELECT chromogenic media for the detection of Methicillin-resistant Staphylococcus aureus. We have also launched a newly modified latex test for the detection of seven different soluble antigens in CSF, Serum and Urine specimens called Pastorex™ Meningitis, offering a highly sensitive, rapid and easy to use test. Bio-Rad offer a wide range of rapid latex tests within our Pastorex™ range for the detection of Staphylococci, Streptococci, Meningitis, Rotavirus, Cryptococcus, Candia, and Aspergillus.
Pall Medical provides a diverse range of filtration membranes to the healthcare market for critical contamination control. Specifically engineered for the filtration of hospital water, respiration, parenteral therapy, general surgical applications and blood component therapy, including autologous applications, our filtration products play a key role in control of healthcare associated infections and blood safety. We are sensitive to the intense pressures for costcontainment and to the increased focus on preventative care. As a result, our emphasis is on not only improving patient outcomes, but also reducing the overall cost of providing that care. We are dedicated to improving the process of all health care applications where filters are required and to creating solutions for our customers. The Pall-Aquasafe Water Filter range includes variants to protect against Legionella spp. or other waterborne microorganisms in water used for drinking or showering. They provide an instantaneous, validated, clinical barrier to the passage of a variety of waterborne contaminants, protecting both hospital staff and patients.
further information
further information
further information visit: www.mastgrp.com or email Anne Kilpatrick: akilpatrick@mastgrp.com
Bio-Rad launch SaSELECT
visit: www.bio-rad.com or email: techsupport.uk@bio-Rad.com. March 2007
visit: www.pall.com Email: biosvc@pall.com